Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming

Cited by (1,000)

Items 501–600 of 1,000

  1. Antioxidant responses related to temozolomide resistance in glioblastoma
    José Angel Campos-Sandoval, María C. Gómez-García, Juan de los Santos-Jiménez, José Manuel Matés, Francisco José Alonso, Javier Márquez · 2021 · Neurochemistry International
  2. Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
    Baishuang Yang, Qiong Chen · 2021 · Oxidative Medicine and Cellular Longevity
  3. Nrf2 promotes mutant K-ras/p53-driven pancreatic carcinogenesis
    Shin Hamada, Keiko Taguchi, Atsushi Masamune, Masayuki P. Yamamoto, Tooru Shimosegawa · 2017 · Carcinogenesis
  4. Metabolic features of cancer cells in NRF2 addiction status
    Okazaki, Keito, Papagiannakopoulos, Thales, Motohashi, Hozumi · 2020 · Biophysical Reviews
  5. Nrf2 Orchestrates Fuel Partitioning for Cell Proliferation
    John D. Hayes, Michael L.J. Ashford · 2012 · Cell Metabolism
  6. Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer
    Fumie Hosoda, Yasuhito Arai, N Okada, Hiroko Shimizu, M Miyamoto, Noriyuki Kitagawa, Hitoshi Katai, Hiroaki Taniguchi, K Yanagihara, Issei Imoto et al. · 2014 · Oncogene
  7. Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients
    Masayuki Kanamori, Tsuyoshi Higa, Yukihiko Sonoda, Shohei Murakami, Mina Dodo, Hiroshi Kitamura, Keiko Taguchi, Tatsuhiro Shibata, Mika Watanabe, Hiroyoshi Suzuki et al. · 2014 · Neuro-Oncology
  8. 6‐Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance
    Iqra Sarfraz, Azhar Rasul, Ghulam Hussain, Muhammad Ajmal Shah, Ameer Fawad Zahoor, Muhammad Asrar, Zeliha Selamoğlu, Xin‐Ying Ji, Şevki Adem, Satyajit Dey Sarker · 2020 · BioFactors
  9. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells
    Diehl, K, Dinges, L-A, Helm, O, Ammar, N, Plundrich, D, Arlt, A, Röcken, C, Sebens, S, Schäfer, H · 2018 · Oncogene
  10. Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2
    Liam Baird, Takafumi Suzuki, Yushi Takahashi, Eiji Hishinuma, Daisuke Saigusa, Masayuki P. Yamamoto · 2020 · Molecular and Cellular Biology
  11. Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival
    Zhongqing Qian, Tong Zhou, Christopher I. Gurguis, Xiaoyan Xu, Qing Wen, Jingzhu Lv, Fang Fang, Louise Hecker, Anne E. Cress, Viswanathan Natarajan et al. · 2015 · Scientific Reports
  12. Ketone body 3‐hydroxybutyrate mimics calorie restriction via the Nrf2 activator, fumarate, in the retina
    Yusuke Izuta, Toshihiro Imada, Ryuji Hisamura, Erina Oonishi, Shigeru Nakamura, Emi Inagaki, Masataka Ito, Tomoyoshi Soga, Kazuo Tsubota · 2017 · Aging Cell
  13. The Specific Inhibition of SOD1 Selectively Promotes Apoptosis of Cancer Cells via Regulation of the ROS Signaling Network
    Xiang Li, Yuanyuan Chen, Jidong Zhao, Jiayuan Shi, Mingfang Wang, Shuang Qiu, Yinghui Hu, Yulin Xu, Yanfang Cui, Chunrong Liu et al. · 2019 · Oxidative Medicine and Cellular Longevity
  14. Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
    Katherine Sellers, Thaddeus D. Allen, Michael Bousamra, Jinlian Tan, Andrés Méndez‐Lucas, Wei Lin, Nourdine Kabirou Bah, Yelena Chernyavskaya, James I. MacRae, Richard M. Higashi et al. · 2019 · British Journal of Cancer
  15. Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
    Makiko Hayashi, Ayumi Kuga, Mikiko Suzuki, Harit Panda, Hiroshi Kitamura, Hozumi Motohashi, Masayuki P. Yamamoto · 2020 · Cancer Research
  16. Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer
    Hiroki Sekine, Hozumi Motohashi · 2021 · Cancers
  17. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance
    Yanchi Chen, Yiling Li, Linyang Huang, Yu Du, Feihong Gan, Yanxi Li, Yang Yao · 2021 · Oxidative Medicine and Cellular Longevity
  18. Keap1–Nrf2 signalling in pancreatic cancer
    Alastair J. Hayes, Christos Skouras, Beate Haugk, Richard Charnley · 2015 · The International Journal of Biochemistry & Cell Biology
  19. Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis
    Kim Ohl, Athanassios Fragoulis, Patricia Klemm, Julian Baumeister, Wiebke Klock, Eva Verjans, Svenja Böll, Julia Möllmann, Michael Lehrke, Ivan G. Costa et al. · 2018 · Frontiers in Immunology
  20. Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?
    Monique G.P. van der Wijst, Robert Eldon Brown, Marianne G. Rots · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  21. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad
    Angelo Sparaneo, Federico Pio Fabrizio, Lucia Anna Muscarella · 2016 · Oxidative Medicine and Cellular Longevity
  22. IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model
    Hiroshi Kitamura, Yoshiaki Onodera, Shohei Murakami, Takashi Suzuki, Hozumi Motohashi · 2017 · Oncogene
  23. A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations
    Daniel C. Levings, Xuting Wang, Derek Kohlhase, Douglas A. Bell, Matthew G. Slattery · 2018 · Redox Biology
  24. “Keaping” a lid on lung cancer: the Keap1-Nrf2 pathway
    Sarah A. Best, Kate D. Sutherland · 2018 · Cell Cycle
  25. RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE–dependent repression
    Pengfei Liu, Montserrat Rojo de la Vega, Saad Sammani, Joseph B. Mascarenhas, Michael John Kerins, Matthew B. Dodson, Xiaoguang Sun, Ting Wang, Aikseng Ooi, Joe G. N. Garcia et al. · 2018 · Proceedings of the National Academy of Sciences
  26. Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes
    Naila Rabbani, Mingzhan Xue, Paul John Thornalley · 2022 · International Journal of Molecular Sciences
  27. Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival
    Jessica Whitburn, Srinivasa R. Rao, Emma V. Morris, Sho Tabata, Akiyoshi Hirayama, Tomoyoshi Soga, James Edwards, Zeynep Kaya, Charlotte Palmer, Freddie Charles Hamdy et al. · 2022 · Science Advances
  28. Nuclear factor erythroid 2-related factor 2 as a treatment target of kidney diseases
    Marie Ito, Tetsuhiro Tanaka, Masaomi Nangaku · 2019 · Current Opinion in Nephrology & Hypertension
  29. Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties
    Aisha Siddiqui, Zahoor Shah, Rao Nargis Jahan, Iekhsan Othman, Yatinesh Kumari · 2021 · Biomedicine & Pharmacotherapy
  30. Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
    Lei Xu, Yuan Cao, XU Ya, Rong Li, Xiaoding Xu · 2023 · Macromolecular Bioscience
  31. Phytochemical Modulators of Mitochondria: The Search for Chemopreventive Agents and Supportive Therapeutics
    Maja Grabacka, Małgorzata Gawin, Małgorzata Pierzchalska · 2014 · Pharmaceuticals
  32. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    Akhileshwar Namani, Qin Cui, Yihe Wu, Hongyan Wang, Xiu Jun Wang, Xiuwen Tang · 2017 · Oncotarget
  33. PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway
    Xudong Yao, Shengnan Yu, Xingzhi Jing, Jiachao Guo, Kai Sun, Fengjing Guo, Yaping Ye · 2020 · Stem Cell Research & Therapy
  34. The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
    Shunsuke Kitajima, Akiyo Yoshida, Susumu Kohno, Fei Li, Sawako Suzuki, Nao Nagatani, Y Nishimoto, Nobunari Sasaki, Hayato Muranaka, Yuansong Wan et al. · 2017 · Oncogene
  35. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression
    Olsi Gjyshi, Arunava Roy, Sujoy Dutta, Mohanan Valiya Veettil, Dipanjan Dutta, Bala Chandran · 2015 · Journal of Virology
  36. AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells
    Brice Sid, Christophe Glorieux, Manuel Valenzuela, Guillaume Rommelaere, Mustapha Najimi, Nicolas Dejeans, Patricia Renard, Julien Verrax, Pedro Buc Calderón · 2014 · Biochemical Pharmacology
  37. Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species
    Sun Park, Mi Jin Lee, Seung Jun Lee, Su Jin Yun, Ji-Young Jang, HanGoo Kang, Kyongmin Hwang Kim, In‐Hong Choi · 2015 · International Journal of Nanomedicine
  38. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
    Masahiro Shimokawa, Tomoharu Yoshizumi, Shinji Itoh, Norifumi Iseda, Kazuhito Sakata, Kyohei Yugawa, Takeo Toshima, Noboru Harada, Toru Ikegami, Masaki Mori · 2020 · Cancer Science
  39. NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation
    Ildikó Szántó · 2022 · International Journal of Molecular Sciences
  40. 4-Octyl Itaconate Regulates Immune Balance by Activating Nrf2 and Negatively Regulating PD-L1 in a Mouse Model of Sepsis
    Peng Zhang, Yaxin Wang, Wengchang Yang, Yuping Yin, Chengguo Li, Xianxiong Ma, Liang Shi, Ruidong Li, Kaixiong Tao · 2022 · International Journal of Biological Sciences
  41. PPIA dictates NRF2 stability to promote lung cancer progression
    Weiqiang Lü, Jiayan Cui, Wanyan Wang, Qian Hu, Yun Xue, Xi Liu, Ting Gong, Yiping Lu, Hui Ma, Xinyu Yang et al. · 2024 · Nature Communications
  42. Targeting of stress response pathways in the prevention and treatment of cancer
    Jaroslav Zelenka, Martina Koncošová, Tomáš Ruml · 2018 · Biotechnology Advances
  43. Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
    Jin Hyang Song, Neha Singh, Libia A. Luevano, Sathish K.R. Padi, Koichi Okumura, Virginie Olive, Stephen M. Black, Noel A. Warfel, David W. Goodrich, Andrew S. Kraft · 2018 · Molecular Cancer Therapeutics
  44. Activation of the NRF2 pathway in Keap1-knockdown mice attenuates progression of age-related hearing loss
    Tetsuya Oishi, Daisuke Matsumaru, Nao Ota, Hiroshi Kitamura, Tianxiang Zhang, Yohei Honkura, Yukio Katori, Hozumi Motohashi · 2020 · npj Aging and Mechanisms of Disease
  45. Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
    DeBlasi, Janine M., Falzone, Aimee, Caldwell, Samantha, Prieto-Farigua, Nicolas, Prigge, Justin R., Schmidt, Edward E., Chio, Iok In Christine, Karreth, Florian A., DeNicola, Gina M. · 2023 · Cancer Research
  46. Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
    Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna · 2024 · International Journal of Molecular Sciences
  47. Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection
    Ludmila Rodrigues Pinto Ferreira, Frederico Moraes Ferreira, Laurie Laugier, Sandrine Cabantous, Isabela Cunha Navarro, Darlan da Silva Cândido, Vagner Oliveira Carvalho Rigaud, Juliana Monte Real, Glaucia Vilar Pereira, Isabela Resende Pereira et al. · 2017 · Scientific Reports
  48. Genetic mutations associated with lung cancer metastasis to the brain
    Hashim M. Aljohani, Mohamed Aittaleb, John Michael Furgason, Peter Amaya, Ayham Deeb, Jeffery J. Chalmers, El Mustapha Bahassi · 2018 · Mutagenesis
  49. MYC-induced metabolic stress and tumorigenesis
    Adam J. Wolpaw, Chi Van Dang · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  50. NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia
    E. Sanchez-Lopez, E. Ghia, L. Antonucci, N. Sharma, L. Rassenti, Jinyi Xu, Bei-Cheng Sun, T. Kipps, M. Karin · 2020 · Cell Death and Differentiation
  51. S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling
    Yeonjin Ko, Mannkyu Hong, Seungbeom Lee, Manoj Kumar, Lara H. Ibrahim, Kayla Nutsch, Caroline R. Stanton, Phillip Sondermann, Braddock A. Sandoval, Maya L. Bulos et al. · 2023 · Proceedings of the National Academy of Sciences
  52. Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
    Barak Rotblat, Thomas G. P. Grünewald, Gabriel Leprivier, Gerry Melino, Richard A. Knight · 2013 · Oncotarget
  53. Glutamine at focus: versatile roles in cancer
    Humberto De Vitto, Juan Alberto Pérez-Valencia, James A. Radosevich · 2015 · Tumor Biology
  54. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers
    Elisa Dama, Valentina Melocchi, Fabio Dezi, Stefania Pirroni, Rose Mary Carletti, Daniela Brambilla, Giovanni Bertalot, Monica Casiraghi, Patrick Maisonneuve, Massimo C.P. Barberis et al. · 2016 · Clinical Cancer Research
  55. MITF protects against oxidative damage-induced retinal degeneration by regulating the NRF2 pathway in the retinal pigment epithelium
    Shuxian Han, Jianjun Chen, Jiajia Hua, Xiaojuan Hu, Shuhui Jian, Guoxiao Zheng, Jing Wang, Huirong Li, Jinglei Yang, James Fielding Hejtmancik et al. · 2020 · Redox Biology
  56. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
    Emiliano Panieri, Luciano Saso · 2021 · Antioxidants and Redox Signaling
  57. The NRF2 antagonist ML385 inhibits PI3K‐mTOR signaling and growth of lung squamous cell carcinoma cells
    Lili Ji, Nadeem Moghal, Xinru Zou, Yixuan Fang, Shuning Hu, Yuhui Wang, Ming‐Sound Tsao · 2022 · Cancer Medicine
  58. FAM3A plays a key role in protecting against tubular cell pyroptosis and acute kidney injury
    Xiaolong Li, Feifei Yuan, Yabing Xiong et al. · 2024 · Redox Biology
  59. Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations
    Frank Rolfs, Marcel Huber, Andreas Kuehne, Stefan Kramer, Eric Haertel, Sukalp Muzumdar, Johanna Wagner, Yasmine Tanner, Friederike Böhm, Sigrun Smola et al. · 2015 · Cancer Research
  60. Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas
    Takayuki Shimizu, Ken-ichi Inoue, Hiroyuki Hachiya, Norisuke Shibuya, Mitsugi Shimoda, Keiichi Kubota · 2013 · Journal of Gastroenterology
  61. Redox signaling regulated by electrophiles and reactive sulfur species
    Motohiro Nishida, Yoshito Kumagai, Hideshi Ihara, Shigemoto Fujii, Hozumi Motohashi, Takaaki Akaike · 2016 · Journal of Clinical Biochemistry and Nutrition
  62. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression
    Danyang Liu, Yonglong Zhang, Yingze Wei, Guoyuan Liu, Yufeng Liu, Qiongmei Gao, Liping Zou, Wenjiao Zeng, Nong Zhang · 2016 · Oncotarget
  63. Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation
    Shunsuke Kitajima, Chiaki Takahashi · 2017 · Cancer Science
  64. Oxidative stress and metabolic reprogramming in Cr(VI) carcinogenesis
    Marco Clementino, Xianglin Shi, Zhuo Zhang · 2017 · Current Opinion in Toxicology
  65. Effects of a DPP4 Inhibitor on Progression of NASH-related HCC and the p62/ Keap1/Nrf2-Pentose Phosphate Pathway in a Mouse Model
    Takumi Kawaguchi, Dan Nakano, Hironori Koga, Takuji Torimura · 2018 · Liver Cancer
  66. Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways
    Reyhaneh Moradi‐Marjaneh, Seyed Mahdi Hassanian, Mehrane Mehramiz, Majid Rezayi, Gordon A. Ferns, Majid Khazaei, Amir Avan · 2018 · Journal of Cellular Physiology
  67. Dynamic palmitoylation controls the microdomain localization of the DKK1 receptors CKAP4 and LRP6
    Ryota Sada, Hirokazu Kimura, Yuko Fukata, Masaki Fukata, Hideki Yamamoto, Akira Kikuchi · 2019 · Science Signaling
  68. The Interplay Between Mitochondrial Reactive Oxygen Species, Endoplasmic Reticulum Stress, and Nrf2 Signaling in Cardiometabolic Health
    Sarah Hartwick Bjorkman, Renata Oliveira Pereira · 2021 · Antioxidants and Redox Signaling
  69. Autophagy in the liver
    Patrice Codogno, Alfred J. Meijer · 2013 · Journal of Hepatology
  70. Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity
    Daisuke Yasuda, Mao Nakajima, Akihiro Yuasa, Rika Obata, Kyôko Takahashi, Tomoyuki Ohe, Yoshinobu Ichimura, Masaaki Komatsu, Masayuki P. Yamamoto, Riyo Maruki Imamura et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
  71. Redox Homeostasis and Natural Dietary Compounds: Focusing on Antioxidants of Rice (Oryza sativa L.)
    Wiramon Rungratanawanich, Maurizio Memo, Daniela Letizia Uberti · 2018 · Nutrients
  72. Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor
    Lu Qiu, Meng Wang, Shaofan Hu, Xufang Ru, Yonggang Ren, Zhengwen Zhang, Siwang Yu, Yiguo Zhang · 2018 · Cancers
  73. The regulation of cardiac intermediary metabolism by NADPH oxidases
    Adam Nabeebaccus, Christina Maria Reumiller, Jie Shen, Anna Zoccarato, Célio X.C. Santos, Ajay M. Shah · 2022 · Cardiovascular Research
  74. Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management
    Safir Ullah Khan, Shahid Ullah Khan, Muhammad Suleman, Shahid Ullah Khan, Muhammad Suleman, Fawad Mueen Arbi, Talib Hussain, Amnah Mohammed Alsuhaibani, Moamen Salah El-Deen Refat · 2023 · Current Problems in Cardiology
  75. Redox regulation of cancer stem cells: Biology and therapeutic implications
    Min Du, Jian Zhang, Max S. Wicha, Ming Luo · 2024 · MedComm – Oncology
  76. SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women
    Yasuko Okano, Uru Nezu, Yasuaki Enokida, Ming Ta Michael Lee, Kinoshita Hiroko, Alexander Lezhava, Yoshihide Hayashizaki, Satoshi Morita, Masataka Taguri, Yasushi Ichikawa et al. · 2013 · PLoS ONE
  77. Reverse engineering the cancer metabolic network using flux analysis to understand drivers of human disease
    Mehmet G. Badur, Christian M. Metallo · 2017 · Metabolic Engineering
  78. Mining a human transcriptome database for chemical modulators of NRF2
    John P. Rooney, Brian N. Chorley, Steven W. Hiemstra, Steven Wink, Xuting Wang, Douglas A. Bell, Bob van de Water, J. Christopher Corton · 2020 · PLoS ONE
  79. Progression-Mediated Changes in Mitochondrial Morphology Promotes Adaptation to Hypoxic Peritoneal Conditions in Serous Ovarian Cancer
    Joseph P. Grieco, Mitchell E. Allen, Justin B. Perry, Yao Wang, Yipei Song, Ali Rohani, Stephanie L. E. Compton, James W. Smyth, Nathan S. Swami, David A. Brown et al. · 2021 · Frontiers in Oncology
  80. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis
    Stephanie Taha‐Mehlitz, Gaia Bianco, Mairene Coto‐Llerena, Venkatesh Kancherla, Glenn R. Bantug, John Gallon, Caner Ercan, Federica Panebianco, Serenella Eppenberger‐Castori, Marco von Strauss et al. · 2021 · Theranostics
  81. The molecular biology and therapeutic potential of Nrf2 in leukemia
    Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh, Shiva Abolhasani, Pooya Jalali, Hamed Mohammadi, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat‐Farsangi, Farhad Jadidi‐Niaragh · 2022 · Cancer Cell International
  82. Advances in Understanding the Role of NRF2 in Liver Pathophysiology and Its Relationship with Hepatic-Specific Cyclooxygenase-2 Expression
    Marina Fuertes‐Agudo, M. Luque-Tévar, Carme Cucarella, Paloma Martín‐Sanz, Marta Casado · 2023 · Antioxidants
  83. Deregulated transcription factors in the emerging cancer hallmarks
    Adria Hasan, Naushad Ahmad Khan, Shahab Uddin M.S., Abdul Q. Khan, Martin S. Steinhoff · 2023 · Seminars in Cancer Biology
  84. Transcription factor NF ‐E2‐related factor 1 impairs glucose metabolism in mice
    Yosuke Hirotsu, Chika Higashi, Toshiaki Fukutomi, Fumiki Katsuoka, Tadayuki Tsujita, Yoko Yagishita, Yuka Matsuyama, Hozumi Motohashi, Akira Uruno, Masayuki P. Yamamoto · 2014 · Genes to Cells
  85. Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?
    Simona Pompili, Roberta Sferra, Eugenio Gaudio, Angelo Viscido, Giuseppe Frieri, Antonella Vetuschi, Giovanni Latella · 2019 · International Journal of Molecular Sciences
  86. An Artemisinin‐Derivative–(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity
    Chen Zhang, Pierre‐Yves Fortin, Guillaume Barnoin, Xue Qin, Xing Wang, Álvaro Fernández Álvarez, Christian Bijani, Marie‐Lise Maddelein, Catherine Hemmert, Olivier Cuvillier et al. · 2020 · Angewandte Chemie International Edition
  87. Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras–Driven Tumor Growth or Metastasis
    Jonathan M. Ghergurovich, Mark Esposito, Zihong Chen, Joshua Z. Wang, Vrushank Dharmesh Bhatt, Taijin Lan, Eileen White, Yibin Kang, Jessie Yanxiang Guo, Joshua D. Rabinowitz · 2020 · Cancer Research
  88. Glutathione System and Oxidative Stress in Health and Disease
    Margarete Dulce Bagatini · 2019 · IntechOpen eBooks
  89. A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy
    Di Zhang, Zhilin Hou, Kelly E. Aldrich, Lizbeth R. Lockwood, Aaron L. Odom, Karen T. Liby · 2021 · Molecular Cancer Therapeutics
  90. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C
    Cong Cheng, Fang Yuan, Xiaoping Chen, Wei Zhang, Xielan Zhao, Zhiping Jiang, Hong‐Hao Zhou, Gan Zhou, Shan Cao · 2021 · Biomedicine & Pharmacotherapy
  91. Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
    Harit Panda, Huaichun Wen, Mikiko Suzuki, Masayuki P. Yamamoto · 2022 · Antioxidants
  92. Ozone Pollution, Oxidative Stress, Regulatory T Cells and Antioxidants
    Selva Rivas-Arancibia, Eduardo Hernández-Orozco, Erika Rodrı́guez-Martı́nez, Marlen Valdés‐Fuentes, Vanessa Cornejo-Trejo, Nelva Pérez-Pacheco, Claudia Dorado-Martı́nez, Diana Zequeida-Carmona, Isaac Espinosa Caleti · 2022 · Antioxidants
  93. NAD Depletion Mediates Cytotoxicity in Human Neurons With Autophagy Deficiency
    Congxin Sun, Elena Seranova, Malkiel A. Cohen, Miruna Chipara, Jennie Roberts, Dewi Astuti, Adina Maria Palhegyi, Animesh Acharjee, Lucia Sedlackova, Tetsushi Kataura et al. · 2022 · Cell Reports
  94. The KEAP1–NRF2 pathway regulates TFEB/TFE3-dependent lysosomal biogenesis
    Athena Jessica S. Ong, Cerys E. Bladen, Tara A. Tigani, Anthony P. Karamalakis, Kimberley Jane Evason, Kristin Brown, Andrew Graham Cox · 2023 · Proceedings of the National Academy of Sciences
  95. Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation
    Dapeng Wang, Yuan Ma, Xu Yang, Xiguo Xu, Yingying Zhao, Zhen Hua Zhu, Xiaojuan Wang, Hanyi Deng, Chunchun Li, Fenfang Gao et al. · 2015 · Free Radical Biology and Medicine
  96. NRF2 Rewires Cellular Metabolism to Support the Antioxidant Response
    Ting-Yu Lin, Lewis C. Cantley, Gina M. DeNicola · 2016 · InTech eBooks
  97. The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling
    Dan Tian, Ying Shi, Dexi Chen, Qiang Liu, Feiyue Fan · 2017 · International Journal of Oncology
  98. Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer
    Kota Arima, Mai Chan Lau, Melissa M. Zhao, Koichiro Haruki, Keisuke Kosumi, Kosuke Mima, Mancang Gu, Juha P. Väyrynen, Tyler S. Twombly, Yoshifumi Baba et al. · 2020 · Molecular Cancer Research
  99. NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer
    Liam Baird, Masayuki P. Yamamoto · 2020 · Molecular and Cellular Biology
  100. The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation
    Yuichiro Matsuoka, Ryoji Yoshida, Kenta Kawahara, Junki Sakata, Hidetaka Arita, Hikaru Nkashima, Nozomu Takahashi, Masatoshi Hirayama, Masashi Nagata, Akiyuki Hirosue et al. · 2022 · Laboratory Investigation